- Q1 2023 Minerva Neurosciences Inc Earnings Call TranscriptMay 15, 2023$6.44 (-11.42%)Earnings
- Q4 2022 Minerva Neurosciences Inc Earnings Call TranscriptMar 08, 2023$1.87 (-7.65%)Earnings
- Q3 2022 Minerva Neurosciences Inc Earnings Call TranscriptNov 09, 2022$3.26 (+8.85%)Earnings
- Minerva Neurosciences Inc Roluperidone Update Call TranscriptApr 13, 2022
- Q3 2021 Minerva Neurosciences Inc Earnings Call TranscriptNov 08, 2021$11.28 (+4.44%)Earnings
- Q2 2021 Minerva Neurosciences Inc Earnings Call TranscriptAug 02, 2021$14.72Earnings
- Minerva Neurosciences Inc at JMP Securities Life Sciences Virtual Conference TranscriptJun 16, 2021
- Minerva Neurosciences Inc Annual Shareholders Meeting TranscriptJun 11, 2021
- Q1 2021 Minerva Neurosciences Inc Earnings Call TranscriptMay 12, 2021$20.64 (+15.70%)Earnings
- Q4 2020 Minerva Neurosciences Inc Earnings Call TranscriptMar 08, 2021$25.52 (+11.54%)Earnings
- Q3 2020 Minerva Neurosciences Inc Earnings Call TranscriptNov 02, 2020$24.8 (-3.43%)Earnings
- Minerva Neurosciences Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Q2 2020 Minerva Neurosciences Inc Earnings Call TranscriptAug 03, 2020$29.52 (+5.88%)Earnings
- Minerva Neurosciences Inc Annual Shareholders Meeting TranscriptJun 19, 2020
- Minerva Neurosciences, Inc. - Special Call TranscriptJun 05, 2020
- Q1 2020 Minerva Neurosciences Inc Earnings Call TranscriptMay 04, 2020$78 (+3.83%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 31, 2020
- Q4 2019 Minerva Neurosciences Inc Earnings Call TranscriptMar 09, 2020$57.6 (-14.59%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 06, 2020
- Minerva Neurosciences, Inc. - Special Call TranscriptDec 18, 2019
- Q3 2019 Minerva Neurosciences Inc Earnings Call TranscriptNov 04, 2019$37.2 (+0.65%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptOct 01, 2019
- Q2 2019 Minerva Neurosciences Inc Earnings Call TranscriptAug 05, 2019$55.76 (+8.06%)Earnings
- Minerva Neurosciences Inc To Discuss The Results Of Its Successful Phase 2b Clinical Trial Of Seltorexant MIN-202 In Insomnia TranscriptJun 24, 2019
- Q1 2019 Minerva Neurosciences Inc Earnings Call TranscriptMay 06, 2019$57.52 (-5.15%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 21, 2019
- Q4 2018 Minerva Neurosciences Inc Earnings Call TranscriptMar 12, 2019$64.88 (-0.37%)Earnings
Minerva Neurosciences, Inc. - Special Call Transcript
Greetings, and welcome to the KOL call on roluperidone, a novel mechanism to treat the negative symptoms of schizophrenia, hosted by Minerva Neuroscience. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Bill Boni, Vice President of Investor Relations and Corporate Communications at Minerva Neurosciences. Please go ahead.
Good morning, and welcome, everyone. On behalf of Minerva, thank you for attending this call, especially given the challenges we are all facing with the coronavirus. Today's speakers include Dr. Ofer Agid, Dr. Will Carpenter, Dr. John Kane and Dr. Stephen Marder.
The discussion will be moderated by Dr. Rémy Luthringer, Executive Chairman and CEO of Minerva. Also present from Minerva, is Dr. Michael Davidson, Chief Medical Officer.
Dr. Agid is Clinician Scientist and Psychiatrist in the Schizophrenia Program and Medical Head, Ambulatory Services and the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)